Detalhe da pesquisa
1.
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
Gen Dent
; 58(6): 484-92; quiz 493-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21062718